Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia 2Mycoses 1Invasive Pulmonary Aspergillosis 1Infections 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Caspofungin × Clear all
NCT00238355 2025-04-27

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

OHSU Knight Cancer Institute

Phase 2 Terminated
13 enrolled 8 charts

Infections

NCT01501708 2016-05-10

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
55 enrolled
Other hematologic neoplasm

Leukemia

NCT00501098 2009-09-22

PROFIL-C

Northern Italy Leukemia Group

Phase 2 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Mycoses, Invasive Pulmonary Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡